This content is from: Premium Glenview Enjoyed a Red-Hot July One of its funds is in the black, while its flagship is down only slightly for the year. By Stephen Taub August 02, 2022
This content is from: Premium Glenview Reports Big Declines in June But Larry Robbins’s hedge funds are still faring much better than the swooning stock indices. By Stephen Taub July 05, 2022
This content is from: Premium Steady Sailing for Glenview in May At Larry Robbins’ hedge fund firm, healthcare is playing a smaller role than it has in the past. By Stephen Taub June 02, 2022
This content is from: Premium Glenview Struggles in April but Remains Flat for the Year Larry Robbins’ healthcare-heavy funds continue to outperform the broad stock averages. By Stephen Taub May 05, 2022
This content is from: Premium Glenview Posts Solid Results in a Tough First Quarter Larry Robbins’ main hedge fund and little-known healthcare fund have so far managed to stay in the black for the year. By Stephen Taub April 04, 2022
This content is from: Premium Glenview Gets Off to a Strong Start Larry Robbins’ healthcare-heavy funds delivered gains in February, outperforming the broader market. By Stephen Taub March 02, 2022
